X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
Investing in India? Get Equitymaster Research  
Banking stocks in limelight 
(Wed, 15 Apr 01:30 pm) 
 
Indian share markets continued to trade weak in the post-noon trading session. Sectoral indices are trading mixed with banking and consumer durables being the major gainers. IT and auto stocks are the biggest losers today.

BSE-Sensex is down 8 points and NSE-Nifty is trading 7 points down. S&P BSE Midcap is trading 0.3% down and S&P BSE Smallcap index is trading down by 0.5%. The rupee is trading at 62.42 to the US dollar.

Indian pharma stocks are trading on a mixed note.Aurobindo Pharma has announced that the company has received final approval for Cefixime oral suspension from USFDA. The approved drug is bio-equivalent to Suprax. The annual market size of the drug is US $123 m as on Feb 2015.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives  RSS
Read the latest Market Commentary
 
BSE-30
 

 
Go
 

Equitymaster requests your view! Post a comment on "Banking stocks in limelight". Click here!

  
 

S&P BSE HEALTHCARE


May 26, 2017 (Close)

MARKET STATS